Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-371a-3p is a small, non-coding RNA molecule belonging to the miR-371-373 cluster on human chromosome 19q13.4[4]. Its main role is *post-transcriptional regulation* of gene expression, primarily through RNA silencing mechanisms. miR-371a-3p is highly expressed in embryonic stem cells and germ cells, and is notably overexpressed in malignant testicular germ cell tumors, but not in mature teratoma. Measurement of serum miR-371a-3p ("M371 test") has emerged as a highly sensitive and specific tool for diagnosing and monitoring testicular germ cell tumors, outperforming classical protein markers such as AFP and β-hCG in both sensitivity and specificity. The molecule is under investigation as a biomarker for treatment monitoring and surveillance in testicular cancer patients[1][2][3][4]. No approved drugs directly target miR-371a-3p, and it is not considered a classical therapeutic target such as a receptor or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-371a-3p (miR-371a-3p).